Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL36AP48, or ribosomal protein L36a pseudogene 48, is a processed pseudogene identified in the human genome[4][5][8][10]. It is related by sequence to the functional ribosomal protein L36a (RPL36A), which is a structural component of the 60S ribosomal subunit, but RPL36AP48 itself does not encode a functional protein. Pseudogenes like RPL36AP48 do not translate into functional proteins; their sequences may sometimes regulate the expression of related protein-coding genes at the RNA level (e.g., via miRNA decoy or siRNA mechanisms), but there is no evidence or specific function documented for this particular pseudogene[2][5][8]. The gene is located on chromosome 17, recognized by identifiers such as HGNC:36721 and Ensembl:ENSG00000213180[4][8][10]. There are no known implications for therapeutic targeting, drug interactions, or biomarker status for RPL36AP48. Its biological and disease relevance is likely limited to basic genomic studies of pseudogene regulation and ribosomal gene evolution. In contrast, its functional relatives, RPL36A and RPL36AL, are active ribosomal protein genes involved in protein synthesis and cellular proliferation[1][3][7][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36a pseudogene 48 (RPL36AP48).